Does Rallies show 13F holders for MLAB?

Yes. Rallies tracks hedge fund and 13F ownership data for MLAB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MLAB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MLAB. It does not provide personalized investment advice.

MLAB (Mesa Laboratories Inc) Stock Analysis - Hedge Fund Holdings

Mesa Laboratories Inc (MLAB) is a publicly traded Technology sector company. As of May 21, 2026, MLAB trades at $103.59 with a market cap of $559.50M and a P/E ratio of 153.44. MLAB moved +4.26% today. Year to date, MLAB is +19.20%; over the trailing twelve months it is -9.82%. Its 52-week range spans $55.45 to $155.12. Analyst consensus is buy with an average price target of $115.00. Rallies surfaces MLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MLAB stock?

Hedge funds tracked by Rallies that own MLAB include Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Mesa Laboratories Inc.

MLAB Key Metrics

Key financial metrics for MLAB
Metric	Value
Price	$103.59
Market Cap	$559.50M
P/E Ratio	153.44
EPS	$0.67
Dividend Yield	0.16%
52-Week High	$155.12
52-Week Low	$55.45
Volume	28
Avg Volume	0
Revenue (TTM)	$247.54M
Net Income	$3.73M
Gross Margin	62.41%

Top Hedge Funds Holding MLAB

Centerbook Partners holds 14.19K shares of MLAB, changed +0.00% as of Mar 31, 2026.

Latest MLAB News

Mesa Laboratories Declares $0.16 Quarterly Dividend Payable June 15 — Apr 2, 2026
Mesa Laboratories Appoints Dr. Siddhartha Kadia CEO Effective April 13, 2026 — Mar 9, 2026
Conestoga Exits Mesa Laboratories After Shares Fall 35.06% Over Year — Feb 20, 2026

Recent MLAB Insider Trades

Ladiwala Shiraz Shabanali bought 3.50K (~$252.81K) on Mar 10, 2026.
Capone Mark Christopher bought 1.30K (~$99.33K) on Mar 10, 2026.
Tripeny R Tony bought 1.31K (~$99.94K) on Mar 10, 2026.

MLAB Analyst Consensus

1 analysts cover MLAB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $115.00.

Common questions about MLAB

Who owns MLAB stock?: Hedge funds tracked by Rallies that own MLAB include Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Mesa Laboratories Inc.
Does Rallies show 13F holders for MLAB?: Yes. Rallies tracks hedge fund and 13F ownership data for MLAB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MLAB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MLAB. It does not provide personalized investment advice.